Company intelligence / Profile preview

Decode Age

Ownership: Private
Development stage: Commercial

Overview

Decode Age offers clinically tested nutraceuticals and diagnostic tests aimed at extending human healthspan. Their products include NMN (a NAD+ booster), Ca-AKG, Senolytics, and India's first comprehensive metagenomic gut microbiome test. The company is ISO/GMP certified with a focus on research-driven product development. No clinical trial results are published; efficacy is based on scientific literature supporting the ingredients used in their products

Therapeutic areas: OtherNeurology
Modalities: Small molecule (for supplements such as NMN and Ca-AKG)NutraceuticalDiagnostic test (Gut Microbiome Test, Blood Biomarker Analysis)
Industry: Food & Nutrition

Drug pipeline

2 assets

LongeVit

Commercial

Indications: Aging

1 more asset in the full pipeline.

Partnerships

Independent labs for product testing (Intertek)No major pharma/biotech partnerships disclosed.

Beyond the preview

Go deeper on Decode Age.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Decode Age.